VKVitalii Kryvenko

Vitalii Kryvenko

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Vitalii Kryvenko has a total of 38 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Sensing molecular carbon dioxide: a translational focus for respiratory disease

    by István Vadász, Eoin P. Cummins, Deborah H. Brotherton, S. Marina Casalino-Matsuda, Laura A. Dada, Ori Green, Dustin T. King, Vitalii Kryvenko, Masahiko Shigemura, Peter H. S. Sporn, et al.

    The last two decades of research on carbon dioxide have demonstrated that CO2 is far more than a waste product of aerobic metabolism leading to acidosis and that it elicits biological responses directly via non-pH-dependent molecular interactions. New specialized methodologies have mapped CO2 incorporation into specific regions of CO2-sensitive proteins and linked these events to altered cellular function. CO2 affects a host of biological responses related to respiratory disease, including control of respiration, protein maturation, alveolar fluid homeostasis, wound repair, innate immunity, host defense, and airway contractility. Elevated CO2 (hypercapnia) appears to be primarily deleterious in pulmonary diseases, leading to a heightened interest in strategies to reduce excess CO2 in patients with hypercapnic respiratory failure. Here, we summarize recently generated knowledge on molecular CO2 sensing and signaling and the potential translational relevance of these processes in the context of respiratory disease. We need to grow this field further by encouraging experts in basic and translational science to contribute to more fully elucidating CO2 sensing, signaling, and downstream effects. Understanding the biology and clinical consequences of perturbations in CO2 homeostasis should no longer be considered secondary to studying oxygen sensing and signaling in respiratory medicine.


  • Identification of molecular mechanisms driving hypercapnia-induced downregulation of protein translation in the alveolar epithelium

    by Vitalii Kryvenko, Elisa Schnell, Werner Seeger, István Vadász

    Hypercapnia is a common complication of acute and chronic lung diseases. Protein synthesis and its key step, protein translation, is one of the crucial determinants of cellular function. Here we investigate how elevated CO2 levels affect protein translation in lung cells and tissues. Exposure of alveolar epithelial cells (AEC) and murine precision-cut lung slices (PCLS) to elevated CO2 concentrations resulted in a significant reduction in global protein translation, as assessed by puromycin incorporation, and was independent of extracellular acidosis. We found that elevated CO2 levels increased the phosphorylation of several kinases involved in the regulation of protein translation, such as eukaryotic initiation factor 2α (eIF2α), cAMP response element-binding protein (CREB), p38 and ribosomal p70 S6. Furthermore, we identified that exposure of AEC to hypercapnia resulted in a rapid increase in eIF2α phosphorylation. Moreover, genetic knockdown by siRNA of four known eIF2α kinases revealed that PKR-like endoplasmic reticulum kinase (PERK) was responsible for the CO2-induced phosphorylation of eIF2α. Neither genetic knockdown of PERK nor chemical inhibition of PERK activity was able to recover protein translation in AEC and PCLS, implying that an alternative pathway may be involved in the hypercapnia-triggered downregulation of protein translation. Elevated CO2 levels reduce global protein translation in AEC and PCLS. Further investigation into the molecular mechanisms underlying these findings could potentially result in the development of novel therapeutic approaches for patients with acute and chronic hypercapnic respiratory failure.

  • Open Access

    Liver stiffness is associated with right heart dysfunction, cardiohepatic syndrome, and prognosis in pulmonary hypertension

    by Zvonimir A. Rako, Athiththan Yogeswaran, Selin Yildiz, Peter Weidemann, Daniel Zedler, Bruno Brito da Rocha, Vitalii Kryvenko, Simon Schäfer, Hossein Ardeschir Ghofrani, Werner Seeger, et al.


  • Hypercapnia increases airway resistance in patients with stable chronic obstructive pulmonary disease

    by Vitalii Kryvenko, Masahiko Shigemura, Werner Seeger, Jacob. I. Sznajder, István Vadász

    Elevated levels of CO2 (hypercapnia) are often observed in patients with chronic obstructive pulmonary disease (COPD). Recently it has been shown that increased CO2, by activating intracellular calcium signalling pathways, might lead to airway obstruction in a preclinical setting. Here, we investigate whether hypercapnia influences airway resistance in patients with COPD. We retrospectively analysed clinical characteristics, blood gases and lung function parameters of 84 patients with COPD GOLD stage 2 – 4, who were recruited in a local registry at the University of Giessen Lung Center between 2014 and 2022. Data were obtained during routine outpatient visits. Partial pressure of oxygen (pO2), carbon dioxide (pCO2) in capillary blood samples and lung function obtained via plethysmography were analysed. Patients were categorised as normocapnic (45 mmHg) based on pCO2 levels. Our results revealed that specific total airway resistance (sRtot) was markedly increased in the group of hypercapnic COPD patients. Moreover, increased sRtot was associated with GOLD stage and was strongly correlated with pCO2 levels. Furthermore, receiver operating characteristic (ROC) analysis showed that even very moderately increased concentrations of pCO2 had high specificity and sensitivity in predicting airway obstruction in patients with COPD. Our data suggest that pCO2 levels are directly associated with airway obstruction in patients with COPD. As already moderate hypercapnia lead to a marked increase in airway resistance, timely correction of elevated pCO2 levels may result in a clinical benefit in this patient group.

  • Open Access

    Clathrin-Mediated Albumin Clearance in Alveolar Epithelial Cells of Murine Precision-Cut Lung Slices

    by Vitalii Kryvenko, Andrés Alberro-Brage, Athanasios Fysikopoulos, Miriam Wessendorf, Khodr Tello, Rory E. Morty, Susanne Herold, Werner Seeger, Christos Samakovlis, István Vadász

    A hallmark of acute respiratory distress syndrome (ARDS) is an accumulation of protein-rich alveolar edema that impairs gas exchange and leads to worse outcomes. Thus, understanding the mechanisms of alveolar albumin clearance is of high clinical relevance. Here, we investigated the mechanisms of the cellular albumin uptake in a three-dimensional culture of precision-cut lung slices (PCLS). We found that up to 60% of PCLS cells incorporated labeled albumin in a time- and concentration-dependent manner, whereas virtually no uptake of labeled dextran was observed. Of note, at a low temperature (4 °C), saturating albumin receptors with unlabeled albumin and an inhibition of clathrin-mediated endocytosis markedly decreased the endocytic uptake of the labeled protein, implicating a receptor-driven internalization process. Importantly, uptake rates of albumin were comparable in alveolar epithelial type I (ATI) and type II (ATII) cells, as assessed in PCLS from a SftpcCreERT2/+: tdTomatoflox/flox mouse strain (defined as EpCAM+CD31−CD45−tdTomatoSPC−T1α+ for ATI and EpCAM+CD31−CD45−tdTomatoSPC+T1α− for ATII cells). Once internalized, albumin was found in the early and recycling endosomes of the alveolar epithelium as well as in endothelial, mesenchymal, and hematopoietic cell populations, which might indicate transcytosis of the protein. In summary, we characterize albumin uptake in alveolar epithelial cells in the complex setting of PCLS. These findings may open new possibilities for pulmonary drug delivery that may improve the outcomes for patients with respiratory failure.


  • Murine precision cut lung slices as a novel 3D-model for studying endocytic pathways in the lung

    by Vitalii Kryvenko, Andrés Alberro Brage, Werner Seeger, Susanne Herold, Christos Samakovlis, István Vadász

    Introduction: Endocytosis plays a pivotal role in cellular and tissue homeostasis. In the lungs, endocytic mechanisms are involved e.g. in phagocytosis, viral infections and receptor-mediated protein uptake. However, the precise lung cell-specific molecular patterns of endocytosis remain poorly understood. Here, we investigated endocytosis in various lung cell types in precision cut lung slices (PCLS), a viable and fully functional 3D lung tissue model system. Results: By using fluorescent-activated cell sorting (FACS) and confocal microscopy, we studied uptake of different proteins and influenza virus (IV) in PCLS. Our results showed that uptake of albumin, transferrin and IV in epithelial (EpCAM+CD31-CD45-), endothelial (EpCAM-CD31+CD45-) and hematopoietic (EpCAM-CD31-CD45+) cells of PCLS was time- and dose-dependent and of different velocity. Treatment with the endocytosis inhibitor, dynasore, and chlorpromazine, an inhibitor of clathrin-mediated endocytic processes, led to decreased uptake of the cargos and IV in a cell-specific manner. Further differences in endocytic capacity were found, when comparing protein and IV uptake in alveolar epithelial type I and type II cells of PCLS. Moreover, we observed that Ras-related proteins, Rab9 and Rab11, and early endosome antigen-1 (EEA1) played a central role in the uptake of proteins and IV in alveolar epithelial cells from PCLS. Conclusions: Our studies suggest that PCLS might serve as a novel 3D-model for studying endocytic mechanisms in respiratory cells. Understanding the molecular pathways of endocytosis in the lung may provide new therapeutic approaches for patients with pulmonary diseases.

  • Hypercapnia-induced calcium dysregulation in the endoplasmic reticulum impairs Na,K-ATPase maturation in precision-cut lung slices and alveolar epithelial cells

    by Vitalii Kryvenko, Miriam Wessendorf, Olga Vagin, Laura A. Dada, Werner Seeger, Jacob I. Sznajder, István Vadász

    Elevated carbon dioxide levels (hypercapnia) are frequently observed in patients with acute and chronic lung diseases. Na,K-ATPase is a sodium transporter and junctional molecule that is critically required for the maintenance of optimal alveolar fluid balance and thus gas exchange. Here, we explored how hypercapnia affects maturation of the Na,K-ATPase in the endoplasmic reticulum (ER). Murine precision-cut lung slices and human alveolar epithelial cells exposed to elevated CO2 levels showed a rapid and dose-dependent reduction of the Na,K-ATPase β-subunit in the ER and decreased Na,K-ATPase plasma membrane abundance. By combining chemical and genetic approaches, we identified that hypercapnia activated inositol-requiring enzyme 1α (IRE1α) and initiated a specific signaling pathway that resulted in ER-associated degradation (ERAD) of the Na,K-ATPase β-subunit. ERAD of the β-subunit prevented assembly with the α-subunit of the enzyme and thus downregulated formation of functional transporter molecules as well as delivery of the complex to the cell surface. Moreover, we observed that IRE1α activation was triggered by changes in ER and cytosolic calcium levels, and were dependent on the activity of the inositol trisphosphate ER receptor (IP3R). Treatment with the IP3R inhibitor, 2-aminoethoxydiphenyl borate (2-APB) prevented calcium dysregulation and increased plasma membrane abundance of the Na,K-ATPase α/β-complex. Accordingly, our results suggest that elevated CO2 levels decrease Na,K-ATPase plasma membrane abundance by altering ER calcium homeostasis and enhancing degradation of the Na,K-ATPase β-subunit in the ER.


  • Open Access

    Hypercapnia Impairs Na,K-ATPase Function by Inducing Endoplasmic Reticulum Retention of the β-Subunit of the Enzyme in Alveolar Epithelial Cells

    by Vitalii Kryvenko, Miriam Wessendorf, Rory E. Morty, Susanne Herold, Werner Seeger, Olga Vagin, Laura A. Dada, Jacob I. Sznajder, István Vadász

    Alveolar edema, impaired alveolar fluid clearance, and elevated CO2 levels (hypercapnia) are hallmarks of the acute respiratory distress syndrome (ARDS). This study investigated how hypercapnia affects maturation of the Na,K-ATPase (NKA), a key membrane transporter, and a cell adhesion molecule involved in the resolution of alveolar edema in the endoplasmic reticulum (ER). Exposure of human alveolar epithelial cells to elevated CO2 concentrations caused a significant retention of NKA-β in the ER and, thus, decreased levels of the transporter in the Golgi apparatus. These effects were associated with a marked reduction of the plasma membrane (PM) abundance of the NKA-α/β complex as well as a decreased total and ouabain-sensitive ATPase activity. Furthermore, our study revealed that the ER-retained NKA-β subunits were only partially assembled with NKA α-subunits, which suggests that hypercapnia modifies the ER folding environment. Moreover, we observed that elevated CO2 levels decreased intracellular ATP production and increased ER protein and, particularly, NKA-β oxidation. Treatment with α-ketoglutaric acid (α-KG), which is a metabolite that has been shown to increase ATP levels and rescue mitochondrial function in hypercapnia-exposed cells, attenuated the deleterious effects of elevated CO2 concentrations and restored NKA PM abundance and function. Taken together, our findings provide new insights into the regulation of NKA in alveolar epithelial cells by elevated CO2 levels, which may lead to the development of new therapeutic approaches for patients with ARDS and hypercapnia.